Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridostigmine in Women With Poor Ovarian Response
IRCT20100518003950N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pyridostigmine in female infertility and poor ovarian response (POR), sponsored by Tehran University of Medical Sciences. Started Aug 2023; status: completed.
02
Drugs
pyridostigmine
03
Conditions
female infertilitypoor ovarian response (POR)
Beyond the preview
Go deeper on IRCT20100518003950N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100518003950N8.